Grafa News and Videos — Page 862

Lindsay (NYSE:LNN) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.38 per share.

AtaiBeckley (NASDAQ:ATAI) announced it completed dosing the final patient in its Phase 2b Elumina clinical trial evaluating VLS-01 for treatment-resistant depression.

AEVEX (NYSE:AVEX) announced it secured a $17.5 million follow-on defense contract under its Global Solutions business segment to continue delivering critical intelligence services.

Natera (NASDAQ:NTRA) announced publication of new clinical data in JAMA Oncology evaluating its Signatera molecular residual disease (MRD) test in patients with resected colorectal liver metastases (CRLM).

High Tide (NASDAQ:HITI) said it has approved a Temporary Shareholder Rights Plan alongside an Amended and Restated Shareholder Rights Plan, both dated June 26, 2026.

Clarivate (NYSE:CLVT) said it has agreed to sell its Life Sciences & Healthcare (LS&H) segment to Altaris for a total consideration of $600 million.

Solstice Advanced Materials (NASDAQ:SOLS), the Honeywell (NASDAQ:HON) spinoff, is in talks to merge with Element Solutions (NYSE:ESI) in a deal that could value the combined company at about $27 billion, including debt.

Oil prices fell on Monday after OPEC+ agreed to increase production targets starting in August, adding pressure to a market already focused on improving global supply conditions.

Kosmos Energy (NYSE:KOS) reported strong operational progress in the first half of 2026, driven by higher production from its Jubilee field in Ghana and steady LNG performance in Mauritania and Senegal.

Molecular Partners (NASDAQ:MOLN) said its Phase 1/2a U.S. study of MP0712 is actively dosing patients in a trial targeting DLL3-positive small cell lung cancer and neuroendocrine tumors.